(FERM BP-174) was found to produce additional 13-lactam components besides the previously reported pluracidomycins (PLM) A, B and C1'. In particular, fermentation at 38`C resulted in an increase of the minor components with a decrease of PLM C, while the yields of PLM A and PLM B remained almost unchanged. Reported here are the isolation and structure elucidation of these minor pluracidomycins. The pluracidomycins were isolated from the fermentation filtrate as previously reported using phase-transfer extraction, ion-exchange chromatography on QAE-Sephadex and gel filtration of the respective fractions to obtain fractions A, B, C and D (in the order of decreasing acidity).
Fraction A containing the main component PLM A, (formerly PLM A), a new minor component PLM A,, and a considerable amount of PLM B, was separated by column chromatography on MCI GEL CHP20P (Mitsubishi Chem. Ind.) using 15°°,' NaCI solution. Fraction B contained a small amount of PLM A., and the second major component PLM B and was separated with a CHP20P column, as was fraction A. The PLM A., portions were combined, desalted by gel filtration on Biogel P-2 and freezedried. Fraction C was further fractionated on CHP20P using 10%, 5',,,' and 2'/',o" NaCI solutions (stepwise) into fractions C,, C,, C, and C4. Fraction C, gave PLM C, (formerly PLM C). The active principles of fractions C, and C, were assumed to be new compounds according to HPLC data but those of fraction C, were identi- Table 1 . The 1H NMR spectrum of PLM A, is closely related to that of PLM A,; some differences were observed in the chemical shifts of the protons at C-4 and C-5, but not in the total proton number and the proton-proton coupling constants. The 13C NMR data (Table 2) , in accordance with 'H NMR, clearly indicated that PLM A., has nine carbon atoms as has PLM A, and differs from PLM A, only in the substituent at C-3. As shown in Table 1 , PLM A, revealed a mobility equal to that of PLM A, and therefore the substituent at C-3 should be an acidic function lacking the carbon atom, like that of PLM A,.
Since the UV absorption (~;. 273 nm) is different from those of PLM A,, B and C,'' the substituent should be a new type of carbapenem antibiotic. Conjecture about its function was based on comparison of the IR spectra (Fig. 2) . The spectrum of PLM A, has a strong band (1200 1270 cm-1) attributable to the S=O stretching of the -SO,,,,-and the -O-SO,-' functions.
In the spectrum of PLM A,, however, the corresponding band is narrowed due to lack of the absorption at 1200 em-1, and two new bands appear at 1020---1060 cm-1 and at 965 cm-1, which may be assignable to the S=O and S-O stretching of a sulfinate3'.
The molecular formula of PLM A., was determined to be PLM A., seems to be the first sulfinic acid identified as a microbial metabolite.
PLM C., is presumably a member of the sulfated olivanic acid group bearing a sulfinyl function at C-3 based on its UV 287 nm) and 'H The X group should be a hydroxyl group, because of the downfield shift of the signals of one methylene group compared with that of asparenomycin B') and the absence of the CH signals due to the X group. Though the sequences of CH were confirmed by spin-spin decoupling experiments, further evidence to confirm the structure could not be obtained due to the limited amount of this component. PLM C. seems to be a precursor of PLM B.
PLM C, was easily deduced to be the sulfoxide of MM 17880 by comparison of its 'H NMR with those of MM 17880 and asparenomycin B. The downfield shift of the proton at C-5 (slightly) and of SCH, (remarkably) clearly shows the sulfinyl structure of the side-chain'). The molecular formula was confirmed to be C,,H,80,-N2S,Na, by SIMS: m/z 455 [M +H]+, 477 [M+ Na]+. Also, the sulfinyl function was easily reduced by titanium trichloride in acetate buffer", and the product was identified as MM 17880 by HPLC.
PLM D has a chromophore (UV i.n.`;-232, 267 nm) similar to that of PLM A, but its paper electrophoresis suggested that presence of only two acidic functions (Table 1) The carbapenem antibiotics are generally labile in aqueous solutions, however, PLM D is fairly stable against hydrolysis at neutral condition. The stability seems to be comparable to that of C-19393 H.,°' (carpetimycin B).
These minor pluracidomycins also showed broad antibacterial and ,3-lactamase inhibitory activities, as will be reported elsewhere.
